Merkel cell carcinoma. Prognosis and management

A. Yiengpruksawan, D. G. Coit, H. T. Thaler, C. Urmacher and W. K. Knapper
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

Seventy patients with Merkel cell carcinoma were treated at Memorial Sloan-kettering Cancer Center between 1969 and 1989. The overall estimated 5-year survival rate was 64%. Factors predictive of improved survival included head and neck site and negative lymph nodes at presentation. Local recurrence was seen in 18 patients (26%) and did not correlate with patient-, tumor-, or treatment-related variables. Nine patients with local recurrence (50%) were free of disease following aggressive reoperation. Regional nodes were involved at some point during the course of the disease in forty-six patients (66%). Regional lymph node involvement was apparent within 2 years of diagnosis in 40 (87%) of 46 patients in whom it occurred. Systemic disease was nearly uniformly preceded by the appearance of nodal metastases and was uniformly fatal regardless of subsequent therapy. This suggests an orderly "cascade" pattern of spread for this tumor, in which elective regional lymph node dissection may be justified. Our recommendations for treatment include a wide excision of the primary tumor and either elective or early therapeutic regional node dissection. The role of adjuvant radiotherapy or chemotherapy remains unproven.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Management of Merkel Cell Carcinoma: The Roles of Lymphoscintigraphy, Sentinel Lymph Node Biopsy and Adjuvant Radiotherapy
Warner et al.
Ann. Surg. Oncol. 2008;15:2509-2518.
ABSTRACT | FULL TEXT  

Merkel Cell Carcinoma Arising in the Ear Canal
Petkovic et al.
INT J SURG PATHOL 2008;16:337-340.
ABSTRACT  

Merkel Cell Carcinoma: Assessing the Effect of Wide Local Excision, Lymph Node Dissection, and Radiotherapy on Recurrence and Survival in Early-Stage Disease--Results From a Review of 82 Consecutive Cases Diagnosed Between 1992 and 2004
Jabbour et al.
Ann. Surg. Oncol. 2007;14:1943-1952.
ABSTRACT | FULL TEXT  

Adjuvant Radiation Therapy Is Associated With Improved Survival in Merkel Cell Carcinoma of the Skin
Mojica et al.
JCO 2007;25:1043-1047.
ABSTRACT | FULL TEXT  

Merkel cell cancer of the skin
Pectasides et al.
Ann Oncol 2006;17:1489-1495.
ABSTRACT | FULL TEXT  

Management of merkel cell carcinoma: what we know.
Alam
Arch Dermatol 2006;142:771-774.
FULL TEXT  

Reliability of Sentinel Lymph Node Biopsy for Regional Staging of Head and Neck Merkel Cell Carcinoma
Schmalbach et al.
Arch Otolaryngol Head Neck Surg 2005;131:610-614.
ABSTRACT | FULL TEXT  

Merkel Cell Carcinoma: Prognosis and Treatment of Patients From a Single Institution
Allen et al.
JCO 2005;23:2300-2309.
ABSTRACT | FULL TEXT  

High-Risk Merkel Cell Carcinoma of the Skin Treated With Synchronous Carboplatin/Etoposide and Radiation: A Trans-Tasman Radiation Oncology Group Study--TROG 96:07
Poulsen et al.
JCO 2003;21:4371-4376.
ABSTRACT | FULL TEXT  

Imaging of Merkel Cell Carcinoma
Nguyen and McCullough
RadioGraphics 2002;22:367-376.
ABSTRACT | FULL TEXT  

Merkel Cell Carcinoma
Goessling et al.
JCO 2002;20:588-598.
FULL TEXT  

Multimodality Treatment of Merkel Cell Carcinoma: Case Series and Literature Review of 1024 Cases
Medina-Franco et al.
Ann. Surg. Oncol. 2001;8:204-208.
ABSTRACT | FULL TEXT  

Chemotherapy in Neuroendocrine/Merkel Cell Carcinoma of the Skin: Case Series and Review of 204 Cases
Tai et al.
JCO 2000;18:2493-2499.
ABSTRACT | FULL TEXT  

Merkel-Cell Carcinomas in Patients Treated with Methoxsalen and Ultraviolet A Radiation
Lunder and Stern
NEJM 1998;339:1247-1248.
FULL TEXT